Loss of α-hemoglobin-stabilizing protein impairs erythropoiesis and exacerbates β-thalassemia. Kong, Y., Zhou, S., Kihm, A., Katein, A., Yu, X., Gell, D., Mackay, J., Adachi, K., Foster-Brown, L., Louden, C., Gow, A., & Weiss, M. Journal of Clinical Investigation, 114(10):1457-1466, 2004. doi abstract bibtex Hemoglobin (Hb) A production during red blood cell development is coordinated to minimize the deleterious effects of free α- and β-Hb subunits, which are unstable and cytotoxic. The α-Hb-stabilizing protein (AHSP) is an erythroid protein that specifically binds α-Hb and prevents its precipitation in vitro, which suggests that it may function to limit free α-Hb toxicities in vivo. We investigated this possibility through gene ablation and biochemical studies. AHSP-/- erythrocytes contained hemoglobin precipitates and were short-lived. In hematopoietic tissues, erythroid precursors were elevated in number but exhibited increased apoptosis. Consistent with unstable α-Hb, AHSP-/- erythrocytes contained increased ROS and evidence of oxidative damage. Moreover, purified recombinant AHSP inhibited ROS production by α-Hb in solution. Finally, loss of AHSP worsened the phenotype of β-thalassemia, a common inherited anemia characterized by excess free α-Hb. Together, the data support a model in which AHSP binds α-Hb transiently to stabilize its conformation and render it biochemically inert prior to Hb A assembly. This function is essential for normal erythropoiesis and, to a greater extent, in β-thalassemia. Our findings raise the possibility that altered AHSP expression levels could modulate the severity of β-thalassemia in humans.
@article{
title = {Loss of α-hemoglobin-stabilizing protein impairs erythropoiesis and exacerbates β-thalassemia},
type = {article},
year = {2004},
pages = {1457-1466},
volume = {114},
id = {b699fcb7-add4-3ff6-a946-b7bf6448eaeb},
created = {2023-01-10T01:46:10.944Z},
file_attached = {false},
profile_id = {a5a2ab6f-a8b5-3db6-97bc-618752ee4386},
group_id = {bc1ab1d4-9e57-37e6-9fb5-435fca0ee9d2},
last_modified = {2023-01-10T01:46:10.944Z},
read = {false},
starred = {false},
authored = {false},
confirmed = {false},
hidden = {false},
private_publication = {false},
abstract = {Hemoglobin (Hb) A production during red blood cell development is coordinated to minimize the deleterious effects of free α- and β-Hb subunits, which are unstable and cytotoxic. The α-Hb-stabilizing protein (AHSP) is an erythroid protein that specifically binds α-Hb and prevents its precipitation in vitro, which suggests that it may function to limit free α-Hb toxicities in vivo. We investigated this possibility through gene ablation and biochemical studies. AHSP-/- erythrocytes contained hemoglobin precipitates and were short-lived. In hematopoietic tissues, erythroid precursors were elevated in number but exhibited increased apoptosis. Consistent with unstable α-Hb, AHSP-/- erythrocytes contained increased ROS and evidence of oxidative damage. Moreover, purified recombinant AHSP inhibited ROS production by α-Hb in solution. Finally, loss of AHSP worsened the phenotype of β-thalassemia, a common inherited anemia characterized by excess free α-Hb. Together, the data support a model in which AHSP binds α-Hb transiently to stabilize its conformation and render it biochemically inert prior to Hb A assembly. This function is essential for normal erythropoiesis and, to a greater extent, in β-thalassemia. Our findings raise the possibility that altered AHSP expression levels could modulate the severity of β-thalassemia in humans.},
bibtype = {article},
author = {Kong, Y. and Zhou, S. and Kihm, A.J. and Katein, A.M. and Yu, X. and Gell, D.A. and Mackay, J.P. and Adachi, K. and Foster-Brown, L. and Louden, C.S. and Gow, A.J. and Weiss, M.J.},
doi = {10.1172/JCI21982},
journal = {Journal of Clinical Investigation},
number = {10}
}
Downloads: 0
{"_id":"sAFxFCcM6wKYuhHcd","bibbaseid":"kong-zhou-kihm-katein-yu-gell-mackay-adachi-etal-lossofhemoglobinstabilizingproteinimpairserythropoiesisandexacerbatesthalassemia-2004","author_short":["Kong, Y.","Zhou, S.","Kihm, A.","Katein, A.","Yu, X.","Gell, D.","Mackay, J.","Adachi, K.","Foster-Brown, L.","Louden, C.","Gow, A.","Weiss, M."],"bibdata":{"title":"Loss of α-hemoglobin-stabilizing protein impairs erythropoiesis and exacerbates β-thalassemia","type":"article","year":"2004","pages":"1457-1466","volume":"114","id":"b699fcb7-add4-3ff6-a946-b7bf6448eaeb","created":"2023-01-10T01:46:10.944Z","file_attached":false,"profile_id":"a5a2ab6f-a8b5-3db6-97bc-618752ee4386","group_id":"bc1ab1d4-9e57-37e6-9fb5-435fca0ee9d2","last_modified":"2023-01-10T01:46:10.944Z","read":false,"starred":false,"authored":false,"confirmed":false,"hidden":false,"private_publication":false,"abstract":"Hemoglobin (Hb) A production during red blood cell development is coordinated to minimize the deleterious effects of free α- and β-Hb subunits, which are unstable and cytotoxic. The α-Hb-stabilizing protein (AHSP) is an erythroid protein that specifically binds α-Hb and prevents its precipitation in vitro, which suggests that it may function to limit free α-Hb toxicities in vivo. We investigated this possibility through gene ablation and biochemical studies. AHSP-/- erythrocytes contained hemoglobin precipitates and were short-lived. In hematopoietic tissues, erythroid precursors were elevated in number but exhibited increased apoptosis. Consistent with unstable α-Hb, AHSP-/- erythrocytes contained increased ROS and evidence of oxidative damage. Moreover, purified recombinant AHSP inhibited ROS production by α-Hb in solution. Finally, loss of AHSP worsened the phenotype of β-thalassemia, a common inherited anemia characterized by excess free α-Hb. Together, the data support a model in which AHSP binds α-Hb transiently to stabilize its conformation and render it biochemically inert prior to Hb A assembly. This function is essential for normal erythropoiesis and, to a greater extent, in β-thalassemia. Our findings raise the possibility that altered AHSP expression levels could modulate the severity of β-thalassemia in humans.","bibtype":"article","author":"Kong, Y. and Zhou, S. and Kihm, A.J. and Katein, A.M. and Yu, X. and Gell, D.A. and Mackay, J.P. and Adachi, K. and Foster-Brown, L. and Louden, C.S. and Gow, A.J. and Weiss, M.J.","doi":"10.1172/JCI21982","journal":"Journal of Clinical Investigation","number":"10","bibtex":"@article{\n title = {Loss of α-hemoglobin-stabilizing protein impairs erythropoiesis and exacerbates β-thalassemia},\n type = {article},\n year = {2004},\n pages = {1457-1466},\n volume = {114},\n id = {b699fcb7-add4-3ff6-a946-b7bf6448eaeb},\n created = {2023-01-10T01:46:10.944Z},\n file_attached = {false},\n profile_id = {a5a2ab6f-a8b5-3db6-97bc-618752ee4386},\n group_id = {bc1ab1d4-9e57-37e6-9fb5-435fca0ee9d2},\n last_modified = {2023-01-10T01:46:10.944Z},\n read = {false},\n starred = {false},\n authored = {false},\n confirmed = {false},\n hidden = {false},\n private_publication = {false},\n abstract = {Hemoglobin (Hb) A production during red blood cell development is coordinated to minimize the deleterious effects of free α- and β-Hb subunits, which are unstable and cytotoxic. The α-Hb-stabilizing protein (AHSP) is an erythroid protein that specifically binds α-Hb and prevents its precipitation in vitro, which suggests that it may function to limit free α-Hb toxicities in vivo. We investigated this possibility through gene ablation and biochemical studies. AHSP-/- erythrocytes contained hemoglobin precipitates and were short-lived. In hematopoietic tissues, erythroid precursors were elevated in number but exhibited increased apoptosis. Consistent with unstable α-Hb, AHSP-/- erythrocytes contained increased ROS and evidence of oxidative damage. Moreover, purified recombinant AHSP inhibited ROS production by α-Hb in solution. Finally, loss of AHSP worsened the phenotype of β-thalassemia, a common inherited anemia characterized by excess free α-Hb. Together, the data support a model in which AHSP binds α-Hb transiently to stabilize its conformation and render it biochemically inert prior to Hb A assembly. This function is essential for normal erythropoiesis and, to a greater extent, in β-thalassemia. Our findings raise the possibility that altered AHSP expression levels could modulate the severity of β-thalassemia in humans.},\n bibtype = {article},\n author = {Kong, Y. and Zhou, S. and Kihm, A.J. and Katein, A.M. and Yu, X. and Gell, D.A. and Mackay, J.P. and Adachi, K. and Foster-Brown, L. and Louden, C.S. and Gow, A.J. and Weiss, M.J.},\n doi = {10.1172/JCI21982},\n journal = {Journal of Clinical Investigation},\n number = {10}\n}","author_short":["Kong, Y.","Zhou, S.","Kihm, A.","Katein, A.","Yu, X.","Gell, D.","Mackay, J.","Adachi, K.","Foster-Brown, L.","Louden, C.","Gow, A.","Weiss, M."],"biburl":"https://bibbase.org/service/mendeley/a5a2ab6f-a8b5-3db6-97bc-618752ee4386","bibbaseid":"kong-zhou-kihm-katein-yu-gell-mackay-adachi-etal-lossofhemoglobinstabilizingproteinimpairserythropoiesisandexacerbatesthalassemia-2004","role":"author","urls":{},"metadata":{"authorlinks":{}}},"bibtype":"article","biburl":"https://bibbase.org/service/mendeley/a5a2ab6f-a8b5-3db6-97bc-618752ee4386","dataSources":["ya2CyA73rpZseyrZ8","4BKYoCQJ3ndMcbbtH","MnayAXw3qciX87bz7","2252seNhipfTmjEBQ"],"keywords":[],"search_terms":["loss","hemoglobin","stabilizing","protein","impairs","erythropoiesis","exacerbates","thalassemia","kong","zhou","kihm","katein","yu","gell","mackay","adachi","foster-brown","louden","gow","weiss"],"title":"Loss of α-hemoglobin-stabilizing protein impairs erythropoiesis and exacerbates β-thalassemia","year":2004}